LYTIR

Company · LH

Labcorp Holdings Inc.

Name as listed on its exchange; filed with the SEC as LABCORP HOLDINGS INC.

Nasdaq's symbol directory lists LH on the New York Stock Exchange as “Labcorp Holdings Inc. Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 11 occasions ($4.8M); 11 planned-sale notices; 14 congressional trade disclosures; 12 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $4.8M in total.Jun: Insider sales $201KJul: Insider sales $93KAug: Insider sales $3.2MOct: Insider sales $389KNov: Insider sales $988KDecJanFebMarAprMayJunJulAugSepOctNov$3.2M
Insider purchases above the line: $0Insider sales below: $4.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Adam H. Schechter, President & CEO sold on 1 day all under a 10b5-1 plan latest Aug 11, 2026 sold $1.5M
  2. ANDERSON KERRII B sold on 1 day all under a 10b5-1 plan latest Aug 17, 2026 sold $954K
  3. Caveney Brian J, EVP, Pres of BLS, CMO & CSO sold on 1 day latest Nov 10, 2026 sold $744K
  4. Wilkinson Peter J, SVP, Chief Accounting Officer sold on 1 day latest Aug 3, 2026 sold $439K
  5. Summy Amy B., EVP, Chief Marketing Officer sold on 2 days latest Nov 16, 2026 sold $419K
  6. Parham Richelle P sold on 1 day latest Oct 30, 2026 sold $389K
  7. Kyle Kathryn W, EVP, Chief Legal Officer sold on 2 days all under a 10b5-1 plan latest Jul 2, 2026 sold $227K
  8. Vaughn Bryan T, EVP and President, Diagnostics sold on 2 days all under a 10b5-1 plan latest Nov 3, 2026 sold $175K
Every trade (11)
  1. SELLSummy Amy B., EVP, Chief Marketing Officer sold Nov 16, 2026 365 shares filing $136K
  2. SELLCaveney Brian J, EVP, Pres of BLS, CMO & CSO sold Nov 10, 2026 2,000 shares filing $744K
  3. SELLVaughn Bryan T, EVP and President, Diagnostics sold Nov 3, 2026 306 shares 10b5-1 plan (scheduled) filing $108K
  4. SELLParham Richelle P sold Oct 30, 2026 1,078 shares filing $389K
  5. SELLANDERSON KERRII B sold Aug 17, 2026 3,000 shares 10b5-1 plan (scheduled) filing $954K
  6. SELLAdam H. Schechter, President & CEO sold Aug 11, 2026 4,669 shares 10b5-1 plan (scheduled) filing $1.5M
  7. SELLSummy Amy B., EVP, Chief Marketing Officer sold Aug 4, 2026 924 shares filing $283K
  8. SELLWilkinson Peter J, SVP, Chief Accounting Officer sold Aug 3, 2026 1,420 shares 2 legs combined filing $439K
  9. SELLVaughn Bryan T, EVP and President, Diagnostics sold Jul 2, 2026 234 shares 10b5-1 plan (scheduled) filing $67K
  10. SELLKyle Kathryn W, EVP, Chief Legal Officer sold Jul 2, 2026 92 shares 10b5-1 plan (scheduled) filing $26K
  11. SELLKyle Kathryn W, EVP, Chief Legal Officer sold Jun 8, 2026 762 shares 10b5-1 plan (scheduled) filing $201K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Summy Amy B. filed Nov 16, 2026 Officer 365 shares planned sale date 11/16/2026 filing $136K
  2. Caveney Brian J filed Nov 10, 2026 Officer 2,000 shares planned sale date 11/10/2026 filing $744K
  3. Bailey Megan D. filed Nov 4, 2026 Former Officer 3,035 shares planned sale date 11/04/2026 filing $1.1M
  4. Vaughn Bryan T filed Nov 3, 2026 Officer 306 shares planned sale date 11/03/2026 filing $108K
  5. Parham Richelle P filed Oct 30, 2026 Director 1,078 shares planned sale date 10/30/2026 filing $389K
  6. KERRII B ANDERSON filed Aug 17, 2026 Director 3,000 shares planned sale date 08/17/2026 filing $954K
  7. Schechter Adam H filed Aug 11, 2026 Officer 4,669 shares planned sale date 08/11/2026 filing $1.5M
  8. Summy Amy B. filed Aug 4, 2026 Officer 924 shares planned sale date 08/04/2026 filing $283K
  9. Vaughn Bryan T filed Jul 2, 2026 Officer 234 shares planned sale date 07/02/2026 filing $67K
  10. Kyle Kathryn W filed Jul 2, 2026 Officer 92 shares planned sale date 07/02/2026 filing $26K
  11. van der Vaart Sandra D filed Jul 1, 2026 Former Officer 7,138 shares planned sale date 07/01/2026 filing $2.0M

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. April McClain Delaney (D-MD06): Sale Aug 25, 2026 reported Sep 9, 2026 one of 78 trades the member reported that day House Stocks (including ADRs) owner: dependent $100,001 - $250,000
  2. April McClain Delaney (D-MD06): Sale Aug 7, 2026 reported Sep 9, 2026 one of 78 trades the member reported that day House Stocks (including ADRs) owner: dependent $1,001 - $15,000
  3. April McClain Delaney (D-MD06): Sale Aug 6, 2026 reported Sep 9, 2026 one of 78 trades the member reported that day House Stocks (including ADRs) owner: dependent $1,001 - $15,000
  4. April McClain Delaney (D-MD06): Sale Aug 5, 2026 reported Sep 9, 2026 one of 78 trades the member reported that day House Stocks (including ADRs) owner: dependent $1,001 - $15,000
  5. Rohit Khanna (D-CA17): Sale Jun 30, 2026 reported Jul 6, 2026 one of 375 trades the member reported that day House owner: spouse $1,001 - $15,000
  6. Rohit Khanna (D-CA17): Purchase May 15, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: spouse $1,001 - $15,000
  7. Alan Armstrong (R-OK): Purchase Mar 27, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000
  8. Tony Wied (R-WI08): Purchase Feb 19, 2026 reported Mar 9, 2026 one of 25 trades the member reported that day House owner: joint $15,001 - $50,000
  9. April McClain Delaney (D-MD06): Purchase Feb 11, 2026 reported Mar 10, 2026 one of 45 trades the member reported that day House Stocks (including ADRs) owner: dependent $1,001 - $15,000
  10. April McClain Delaney (D-MD06): Purchase Feb 4, 2026 reported Mar 10, 2026 one of 45 trades the member reported that day House Stocks (including ADRs) owner: dependent $1,001 - $15,000
  11. Rohit Khanna (D-CA17): Sale Jan 29, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: spouse $1,001 - $15,000
  12. April McClain Delaney (D-MD06): Purchase Jan 28, 2026 reported Feb 2, 2026 one of 15 trades the member reported that day House Stocks (including ADRs) owner: dependent $1,001 - $15,000
  13. Rohit Khanna (D-CA17): Sale Jan 22, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: dependent $1,001 - $15,000
  14. Rohit Khanna (D-CA17): Sale Jan 12, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: dependent $1,001 - $15,000

Executive branch · OGE Form 278-T

Reported by the President

2 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports

  1. Purchase: LABCORP HOLDINGS INC May 11, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $100,001 – $250,000
  2. Sale: LABCORP HOLDINGS INC Apr 10, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $15,001 – $50,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Nov 4, 2026
  2. Results of operations and financial condition filing Oct 28, 2026
  3. Regulation FD disclosure filing Oct 21, 2026
  4. Regulation FD disclosure filing Sep 30, 2026
  5. Regulation FD disclosure filing Sep 22, 2026
  6. Regulation FD disclosure filing Sep 10, 2026
  7. Regulation FD disclosure filing Aug 28, 2026
  8. Regulation FD disclosure filing Aug 17, 2026
  9. Departure or appointment of directors or officers filing Aug 14, 2026
  10. Results of operations and financial condition filing Jul 30, 2026
  11. Regulation FD disclosure filing Jul 10, 2026
  12. Regulation FD disclosure filing Jun 30, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K), OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.